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Background:  In several clinical studies, following treatment for acute decompensated heart failure (ADHF), brain natriuretic peptide 
(BNP) has been used as a biomarker of decongestion. However, there are some cases in which BNP levels increases despite resolution of 
signs and symptoms of congestion. Although several approaches have been used to estimate the hydration status, the accurate and fast 
estimation of body fluid content has always been challenging in acute care settings. Recently, the utility of multi-frequency bio-impedance 
analysis (MFBIA) has been demonstrated in evaluating fluid congestion in ADHF.
methods:  We studied 75 consecutive patients (77±12 years, 47% men, left ventricular ejection fraction 37±15%) admitted to our hospital 
with symptoms of ADHF. Patients with cardiogenic shock, hemodialysis, bleeding, and implanted materials that could interfere with MFBIA 
were excluded. Congestion index (CI), representing as the ratio of extracellular water to whole-body water, was assessed using MFBIA. 
Serial measurements of BNP levels and CI were performed at admission, on days 2, 5, and at discharge.
results:  During hospitalization, BNP levels and CI significantly decreased (from 928 [566-1434] to 297 [169-623] pg/ml, and from 
0.413±0.016 to 0.405±0.014, respectively, both p<0.01). The changes in BNP levels correlated with those in CI (r=0.26, p=0.02). 
Nevertheless, there were no correlations between changes in BNP levels and CI from admission to day 2 (r=-0.04, p=0.73) and from 
admission to day 5 (r=0.11, p=0.34). This mismatch was noted in 17 (23%) patients, who exhibited an increase in BNP levels (from 767 
[550-1259] to 1041 [670-1630] pg/ml, p<0.01) as opposed to a CI decline (from 0.419±0.014 to 0.409±0.013, p<0.001). Logistic regression 
analysis demonstrated that lower tricuspid annular plane systolic excursion on echocardiography performed at the emergency department 
was the only predictor of a mismatch (OR: 0.84, 95% CI 0.71-0.99, p=0.04).
conclusion:  In ADHF patients with right ventricular dysfunction, BNP level assessment might not be a valid methodology to guide those 
patients toward maintenance of an appropriate fluid status following decongestion therapy.
